Join the Class Action for Baxter International Shareholders
The Gross Law Firm has recently announced a significant step for the shareholders of Baxter International, Inc. (NYSE: BAX). This announcement comes amid serious allegations against the company regarding its product safety and transparency.
Understanding the Case
Recent claims have surfaced that Baxter has made materially false and misleading statements during the class period, which runs from February 23, 2022, to July 30, 2025. These statements are said to relate to the safety and efficacy of their newly launched product, the Novum LVP. Allegedly, this device has serious systemic defects leading to malfunctions such as underinfusion and complete non-delivery of fluids, posing significant health risks to patients.
Details of the Allegations
The core allegations highlight that Baxter was informed about various malfunctions linked to the Novum LVP. However, the company's attempts to mitigate these risks through customer alerts were deemed inadequate. Stakeholders may have been misled by Baxter’s optimistic outlook regarding the product rollout and customer feedback, which does not reflect the grave situation around the safety of the device.
Important Deadlines for Shareholders
Potential participants must be aware that the deadline to register for this class action suit is December 15, 2025. As a shareholder who purchased BAX shares within the specified class period, you are highly encouraged to register your information promptly. This step is crucial for securing potential recovery in case the lawsuit favors the plaintiffs.
What Should You Do Next?
Once you register, you will access a portfolio monitoring software that provides case status updates. This service works to keep shareholders informed every step of the way without charging any fees or imposing obligations on the participants. Enrolling in this monitoring system ensures that you stay updated on any significant developments in the case.
Why Choose The Gross Law Firm?
The Gross Law Firm is recognized nationwide for its commitment to protecting investor rights. Its mission focuses on ensuring that companies adhere to ethical business practices and maintain transparency with shareholders. The firm is dedicated to seeking recovery for investors affected by potentially misleading statements made by the firms they invest in. Their experience may be pivotal in guiding affected shareholders through this challenging phase.
Contact Information
If you are interested in learning more or participating in this class action lawsuit, you can do so by contacting the Gross Law Firm. They have established themselves as a leader in investor rights protection and can provide you with detailed information on the steps to take.
Contact Details:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
Frequently Asked Questions
What is the class action about?
The class action addresses allegations of misleading statements made by Baxter International regarding the safety of their Novum LVP product.
Who can join this class action lawsuit?
Shareholders who purchased shares of BAX during the class period of February 23, 2022, to July 30, 2025, can participate.
What are the deadlines to be aware of?
The key deadline to register for the class action is December 15, 2025.
What happens once I register?
Upon registration, you will be enrolled in a monitoring system for ongoing case updates, free of charge.
Why is my participation important?
Your involvement is crucial as it may increase the likelihood of a successful resolution of the case, leading to potential recovery for shareholders.
